85-2052-83 APRIL, Recombinant, Mouse (TNFSF13, A Proliferation-inducing Ligand, CD256, TALL2, TRDL1, ZTNF2) 10ug 167627

※お見積書はカートで印刷できます

冷凍

特徴

  • APRIL (a proliferation­inducing ligand), also known as TNFSF13, TALL2, TRDL1, and CD256, is a member of the TNF ligand superfamily (1). It is synthesized as a 32kD proprotein which is cleaved by furin in the Golgi to release the active 17kD soluble molecule (2­4). Secreted mouse APRIL, which consists almost entirely of a single TNF homology domain, shares 85% and 95% amino acid sequence identity with human and rat APRIL, respectively (2, 3). Both APRIL and its close relative BAFF bind and signal through the TNF superfamily receptors TACI and BCMA, while BAFF additionally functions through BAFF R (2, 5, 6). APRIL binds to heparan sulfate proteoglycans (HSPGs) independently of its binding to TACI and BCMA (6, 7). The interaction with HSPGs induces APRIL oligomerization, and this augments TACI­, or BMCA­mediated effects (7, 8). HSPGs are also critical for the tumor growth­promoting effects attributed to APRIL (6). APRIL can form bioactive heterotrimers with BAFF, and these circulate in the serum of patients with rheumatic immune disorders (10). TWE­PRIL is a bioactive hybrid protein produced by gene splicing. It consists of the intracellular domain, transmembrane segment, and stalk region of TWEAK fused to the TNF homology domain of APRIL (11). TWE­PRIL is expressed in monocytes and activated T cells and, in contrast to APRIL, is presented on the cell surface (11). APRIL enhances the proliferation and survival of plasma cells and also promotes T cell­dependent humoral responses (2, 12, 13). In the context of autoimmune disorders, however, APRIL can inhibit pathologic humoral responses as well as disease progression (14). Its expression by CD4+ T cells inhibits the production of Th2 cytokines and allergic inflammation (15). APRIL levels are elevated in the serum during coronary artery disease (16), and it is also elevated in many cancers primarily due to expression by tumor­infiltrating neutrophils (4, 7, 17).
  • Source:Recombinant protein corresponding to mouse APRIL, CHO-derived.
  • Molecular Weight:~21.8kD
  • Endotoxin:<0.10 EU/1ug
  • Biological Activity:Measured in a cell proliferation assay using anti-IgM stimulated mouse B cells. The ED50 for this effect is typically 0.5-3ng/ml
  • Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

  • Size:10ug
  • Source Antigen:Recombinant, CHO
  • Grade:Highly Purified
  • Purity:~95% (SDS-PAGE)
  • Form:Supplied as a lyophilized powder in Tris, NaCl, BSA. Reconstitute with 100ug/ml ddH2O.
  • Molecular Weight Non Ab:21.8
  • EU Commodity Code:30021019
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-2052-83
型番
167627
入り数
1個
標準価格
229,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る